• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
A Scottish national audit of current patterns of management for patients with testicular non-seminomatous germ-cell tumours. The Scottish Radiological Society and the Scottish Committee of the Royal College of Radiologists.一项关于睾丸非精原细胞瘤患者当前管理模式的苏格兰全国性审计。苏格兰放射学会和皇家放射科医师学院苏格兰委员会。
Br J Cancer. 1995 Nov;72(5):1303-6. doi: 10.1038/bjc.1995.505.
2
Referral patterns within Scotland to specialist oncology centres for patients with testicular germ cell tumours. The Scottish Radiological Society and the Scottish Standing Committee of the Royal College of Radiologists.苏格兰睾丸生殖细胞肿瘤患者转诊至专科肿瘤中心的模式。苏格兰放射学会和皇家放射科医师学院苏格兰常务委员会。
Br J Cancer. 1995 Nov;72(5):1300-2. doi: 10.1038/bjc.1995.504.
3
A Scottish national mortality study assessing cause of death, quality of and variation in management of patients with testicular non-seminomatous germ-cell tumours. The Scottish Radiological Society and the Scottish Standing Committee of the Royal College of Radiologists.一项苏格兰全国性死亡率研究,评估睾丸非精原细胞瘤生殖细胞肿瘤患者的死因、治疗质量及差异。苏格兰放射学会和皇家放射科医师学院苏格兰常务委员会。
Br J Cancer. 1995 Nov;72(5):1307-11. doi: 10.1038/bjc.1995.506.
4
Germ cell tumours in uncorrected cryptorchid testis at Institute Rotary Cancer Hospital, New Delhi.新德里扶轮癌症医院未矫正隐睾中的生殖细胞肿瘤。
Br J Cancer. 1995 Feb;71(2):380-2. doi: 10.1038/bjc.1995.77.
5
Risk-adapted management for patients with clinical stage I non-seminomatous germ cell tumour of the testis.睾丸临床I期非精原细胞性生殖细胞肿瘤患者的风险适应性管理。
Med Oncol. 2009;26(2):136-42. doi: 10.1007/s12032-008-9095-6. Epub 2008 Sep 26.
6
Bilateral testicular germ cell tumors in patients treated for clinical stage I non-seminoma within two risk-adapted SWENOTECA protocols.在两项风险适应性SWENOTECA方案中接受临床I期非精原细胞瘤治疗的患者发生双侧睾丸生殖细胞肿瘤。
Acta Oncol. 2015 Apr;54(4):493-9. doi: 10.3109/0284186X.2014.953256. Epub 2014 Sep 5.
7
Changes in the incidence and mortality of testicular cancer in Scotland with particular reference to the outcome of older patients treated for non-seminomatous germ cell tumours.苏格兰睾丸癌发病率和死亡率的变化,特别提及老年非精原细胞瘤性生殖细胞肿瘤患者的治疗结果。
Eur J Cancer. 1995;31A(9):1487-91. doi: 10.1016/0959-8049(95)00298-w.
8
[Urologic treatment of testicular germ cell cancer].睾丸生殖细胞癌的泌尿外科治疗
Arch Esp Urol. 2002 Oct;55(8):927-36.
9
Testis cancer: a 20-year epidemiological review of the experience at a regional military medical facility.睾丸癌:对某地区军事医疗设施20年经验的流行病学回顾。
J Urol. 2008 Aug;180(2):577-81; discussion 581-2. doi: 10.1016/j.juro.2008.04.032. Epub 2008 Jun 12.
10
Diagnosis and treatment of patients with testicular germ cell cancer.睾丸生殖细胞癌患者的诊断与治疗
Drugs. 1999 Aug;58(2):257-81. doi: 10.2165/00003495-199958020-00004.

引用本文的文献

1
Management of patients with low-stage nonseminomatous germ cell testicular cancer.低分期非精原细胞性生殖细胞睾丸癌患者的管理
Curr Treat Options Oncol. 2005 Sep;6(5):367-77. doi: 10.1007/s11864-005-0040-z.
2
A Scottish national mortality study assessing cause of death, quality of and variation in management of patients with testicular non-seminomatous germ-cell tumours. The Scottish Radiological Society and the Scottish Standing Committee of the Royal College of Radiologists.一项苏格兰全国性死亡率研究,评估睾丸非精原细胞瘤生殖细胞肿瘤患者的死因、治疗质量及差异。苏格兰放射学会和皇家放射科医师学院苏格兰常务委员会。
Br J Cancer. 1995 Nov;72(5):1307-11. doi: 10.1038/bjc.1995.506.
3
Referral patterns within Scotland to specialist oncology centres for patients with testicular germ cell tumours. The Scottish Radiological Society and the Scottish Standing Committee of the Royal College of Radiologists.苏格兰睾丸生殖细胞肿瘤患者转诊至专科肿瘤中心的模式。苏格兰放射学会和皇家放射科医师学院苏格兰常务委员会。
Br J Cancer. 1995 Nov;72(5):1300-2. doi: 10.1038/bjc.1995.504.

本文引用的文献

1
Current issues in the management of clinical stage I testicular teratoma.临床I期睾丸畸胎瘤管理中的当前问题
Eur J Cancer. 1993;29A(7):933-4. doi: 10.1016/s0959-8049(05)80195-9.
2
Management of malignant teratoma: does referral to a specialist unit matter?恶性畸胎瘤的管理:转诊至专科单位重要吗?
Lancet. 1993 Apr 17;341(8851):999-1002. doi: 10.1016/0140-6736(93)91082-w.
3
Referral patterns within Scotland to specialist oncology centres for patients with testicular germ cell tumours. The Scottish Radiological Society and the Scottish Standing Committee of the Royal College of Radiologists.苏格兰睾丸生殖细胞肿瘤患者转诊至专科肿瘤中心的模式。苏格兰放射学会和皇家放射科医师学院苏格兰常务委员会。
Br J Cancer. 1995 Nov;72(5):1300-2. doi: 10.1038/bjc.1995.504.
4
Orchidectomy alone in testicular stage I non-seminomatous germ-cell tumours.
Lancet. 1982 Sep 25;2(8300):678-80. doi: 10.1016/s0140-6736(82)90710-3.
5
Surgical salvage of advanced testicular tumours.晚期睾丸肿瘤的手术挽救治疗。
Br J Urol. 1987 Jan;59(1):76-80. doi: 10.1111/j.1464-410x.1987.tb04585.x.
6
The role of surgery in the combined management of metastases from malignant teratomas of testis.手术在睾丸恶性畸胎瘤转移联合治疗中的作用。
Br J Urol. 1987 Apr;59(4):358. doi: 10.1111/j.1464-410x.1987.tb04649.x.
7
Carcinoma in situ of the testis.睾丸原位癌
Br Med J (Clin Res Ed). 1986 Nov 29;293(6559):1389-90. doi: 10.1136/bmj.293.6559.1389.
8
Germ cell tumour chemotherapy.生殖细胞肿瘤化疗
Br J Cancer. 1989 Feb;59(2):156-9. doi: 10.1038/bjc.1989.33.
9
Surgery following chemotherapy for metastatic testicular teratoma.转移性睾丸畸胎瘤化疗后的手术治疗
Br J Urol. 1991 Sep;68(3):292-5. doi: 10.1111/j.1464-410x.1991.tb15326.x.
10
Compliance with follow-up of patients treated for non-seminomatous testicular cancer.非精原细胞瘤性睾丸癌治疗患者随访的依从性。
Br J Cancer. 1991 Sep;64(3):606-8. doi: 10.1038/bjc.1991.359.

一项关于睾丸非精原细胞瘤患者当前管理模式的苏格兰全国性审计。苏格兰放射学会和皇家放射科医师学院苏格兰委员会。

A Scottish national audit of current patterns of management for patients with testicular non-seminomatous germ-cell tumours. The Scottish Radiological Society and the Scottish Committee of the Royal College of Radiologists.

作者信息

Howard G C, Clarke K, Elia M H, Hutcheon A W, Kaye S B, Windsor P M

机构信息

Department of Clinical Oncology, Western General Hospital, Edinburgh, UK.

出版信息

Br J Cancer. 1995 Nov;72(5):1303-6. doi: 10.1038/bjc.1995.505.

DOI:10.1038/bjc.1995.505
PMID:7577487
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2033928/
Abstract

A detailed casenote review was performed on all 65 patients registered with testicular non-seminomatous germ cell tumours (NSGCT) during 1989 under the Scottish Cancer Registration Scheme. Details of management at presentation and 2 years following diagnosis were recorded and analysed. In a small number of patients an unacceptable delay in diagnosis was noted. Variation was found in the frequency and type of investigations performed on patients placed on surveillance, types of chemotherapy regimens used and numbers of patients entered into trials. Three per cent of patients had a biopsy of the contralateral testis and 27% of patients defaulted from clinic attendance. Considerable variation in the management of testicular NSGCT in Scotland has been identified. The introduction of management guidelines should result in a more consistent approach to the care of these patients. Support, both financial and psychological, may reduce the unacceptable rate of default.

摘要

对1989年根据苏格兰癌症登记计划登记的所有65例睾丸非精原细胞瘤生殖细胞肿瘤(NSGCT)患者进行了详细的病例记录回顾。记录并分析了就诊时及诊断后2年的治疗细节。在少数患者中,发现诊断存在不可接受的延迟。对接受监测的患者进行的检查频率和类型、使用的化疗方案类型以及进入试验的患者数量存在差异。3%的患者对侧睾丸进行了活检,27%的患者未按预约就诊。已确定苏格兰睾丸NSGCT的治疗存在相当大的差异。引入管理指南应能使这些患者的护理方法更加一致。经济和心理支持可能会降低不可接受的失约率。